Ipratropium
ArticlesLactation Safety Information · Published , updated
108624006
Articles
27 October 2020
Safety in Lactation: Topical nasal decongestants
Drugs used for nasal decongestion have limited systemic absorption in the mother, and pose negligible risk to a breastfed infant. There is no published evidence… Ephedrine Ipratropium Safety in Breastfeeding Xylometazoline
25 September 2020
Safety in Lactation: Drugs for obstructive airways disease
Additional information relating to breastfeeding To be used in conjunction with individual drug entries for specific information and guidance. Bronchodilators Most bronchodilators are considered to… Aclidinium bromide Aminophylline Bambuterol Beclometasone Budesonide Ciclesonide Ephedrine Fluticasone Formoterol Glycopyrronium Ipratropium Mepolizumab Mometasone Montelukast Nedocromil Obstetrics and gynaecology Omalizumab Paediatrics and neonates Respiratory disorders Roflumilast Safety in Breastfeeding Salbutamol Salmeterol Sodium cromoglicate Theophylline Tiotropium Umeclidinium bromide Umeclidinium bromide + Vilanterol Zafirlukast
27 February 2020
Which commonly used nebuliser solutions are compatible?
Mixing of nebuliser solutions should only be undertaken in the best interests of the patient and only by a person competent and willing to do… Budesonide Colistimethate Fluticasone Ipratropium Respiratory disorders Salbutamol Salbutamol + Ipratropium Terbutaline Tobramycin
13 December 2019
Ethanol content of inhalers – What is the significance?
Ethanol is included as an excipient in many commonly prescribed inhalers, including some licensed for use in children. Patients may have ethical, religious or cultural… Beclometasone Beclometasone + Formoterol Beclometasone + Formoterol + Glycopyrronium bromide Budesonide + Formoterol Ethanol Excipients Fluticasone + Formoterol Formoterol Ipratropium Respiratory disorders Salbutamol Salbutamol + Beclometasone
1 August 2018
Hypersalivation – what are the treatment alternatives to glycopyrronium and hyoscine?
This Medicines Q&A outlines possible alternatives to hyoscine hydrobromide and glycopyrronium in the treatment of non drug-induced hypersalivation, e.g. botulinum toxin, amitriptyline, atropine (eye drops… Administering Amitriptyline Atropine Benzatropine Botulinum A toxin Cisapride Dosing Glycopyrronium Hyoscine (base) Hyoscine hydrobromide Ipratropium Metoprolol Modafinil Neurological disorders Piracetam Propranolol Publications Ranitidine Rotigotine Trihexyphenidyl
1 August 2018
Drug-induced hypersalivation – what treatment options are available?
This Medicines Q&A summarises published studies or case reports concerning the pharmacological treatment of drug-induced hypersalivation (drooling or sialorrhoea), particularly hypersalivation caused by clozapine. Update… Administering Amisulpride Atropine Benzatropine Biperiden Botulinum A toxin Bupropion Clonidine Clozapine Dosing Glycopyrronium Guanfacine Hyoscine butylbromide Hyoscine hydrobromide Ipratropium Lofexidine Mental Health Mental health and illness Metoclopramide Moclobemide Neurological disorders Oxybutynin Pirenzepine Propantheline Publications Quetiapine Sulpiride Trihexyphenidyl Unlicensed medicinesLactation Safety Information
Inhalation
Inhalation
-
Antimuscarinic bronchodilator
No published evidence of safety
Low levels anticipated in milk due to the drug’s properties
Used in infants >1 month
31 July 2020
Intranasal
Intranasal
31 July 2020